翻訳と辞書 |
erlizumab
Erlizumab, also known as rhuMAb, is a recombinant humanized monoclonal antibody that was an experimental immunosuppressive drug. Erlizumab was developed by Genentech under a partnership with Roche to treat heart attack, stroke, and traumatic shock. == Mechanism of action ==
The drug works by blocking a growth factor in blood vessels.〔 Specifically, erlizumab targets CD18 and an LFA-1 integrin. Erlizumab was meant to stop lymphocyte movement into inflamed tissue, thereby reducing tissue damage.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「erlizumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|